Literature DB >> 8053111

Update on diagnosis of canine hypothyroidism.

D C Ferguson1.   

Abstract

Until a clinically useful canine TSH assay is available, a valid test of thyroid hypofunction should (1) take into consideration valid (or at least predictive) measurement of the free T4 concentration in order to factor out the binding effects of drugs and nonthyroidal illness, and (2) should assess thyroid functional reserve. A validated equilibrium dialysis measurement of free T4 and the TSH stimulation test, provide the most useful diagnostic combination of tests now available. A therapeutic trial with L-thyroxine, despite being relatively safe, should be reserved once other diagnoses have been ruled out, and should be reevaluated to assure a clinical response which can be attributable to the medication.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8053111     DOI: 10.1016/s0195-5616(94)50057-3

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  6 in total

1.  Use of recombinant human thyroid-stimulating hormone for thyrotropin stimulation test in euthyroid dogs.

Authors:  F Sauvé; M Paradis
Journal:  Can Vet J       Date:  2000-03       Impact factor: 1.008

2.  Usefulness of a chromatographic method to detect circulating antithyroid hormone autoantibodies in canine serum.

Authors:  S Savastano; A P Tommaselli; R Valentino; M Dorato; M T Scarpitta; A Persechino; P Ciaramella; G Lombardi
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

3.  Serum-free thyroxine concentrations, measured by chemiluminescence assay before and after thyrotropin administration in healthy dogs, hypothyroid dogs, and euthyroid dogs with dermathopathies.

Authors:  M Paradis; N Pagé; N Larivière; M Fontaine
Journal:  Can Vet J       Date:  1996-05       Impact factor: 1.008

4.  Effects of oral administration of meloxicam, carprofen, and a nutraceutical on thyroid function in dogs with osteoarthritis.

Authors:  Frédéric Sauvé; Manon Paradis; Kent R Refsal; Maxim Moreau; Guy Beauchamp; Jacques Dupuis
Journal:  Can Vet J       Date:  2003-06       Impact factor: 1.008

5.  Nonthyroidal illness syndrome in adult horses.

Authors:  A C Hilderbran; B A Breuhaus; K R Refsal
Journal:  J Vet Intern Med       Date:  2014-01-13       Impact factor: 3.333

6.  Characterization of recombinant human and bovine thyroid-stimulating hormone preparations by mass spectrometry and determination of their endotoxin content.

Authors:  Sandra Schaefer; Paul O Hassa; Nadja S Sieber-Ruckstuhl; Marion Piechotta; Claudia E Reusch; Bernd Roschitzki; Felicitas S Boretti
Journal:  BMC Vet Res       Date:  2013-07-16       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.